The legacy of Charles Darwin
This year marks the 140th anniversary of the death of Charles Darwin. And the 163rd anniversary of the publication of his book The Origin of Species. Darwin is the most
The continuing struggle to control weeds
An article in Chemical and Engineering News calls our attention to the struggle to control weeds. Will we be able to control weeds in the future? Will the EU, that
Are mutation rates constant? Evolution theory still in development
For a long time, biology held that mutation rates are random. Biologists assumed that mutations occur anywhere in the genome, in principle at the same rate everywhere. That some mutations
Defy death – will they ever succeed?
A number of powerful people has embarked on a mission to defy death. The most recent among these is Jeff Bezos, former CEO of Amazon and one of the five
The myth of pristine nature
We often assume that ecosystems existed in a pristine state when Western researchers first encountered them. But new research now undermines this concept of pristine nature. Ever since mankind existed,
RethinkX, an evaluation
The recent RethinkX project expects the ‘20s of this century to show revolutionary developments. Driven by stepwise changes in five key sectors of the economy: energy, transport, information, food and
The RethinkX project
Over the past few years, the RethinkX project has made the case for yet another revolution to come. Based on major leaps forward in many technologies; in particular in the
Do we need to regulate Big Pharma?
In Dutch newspaper NRC of July 23, 2022, Joost Smiers tackles the problem of the sky-high prices of medication. Do we still need Big Pharma? he asks. And he answers:
on: 31 July 2022